← Open Payments lookup

AMIE ALEXANDER: Open Payments

NPI 1104198266 · GULFPORT, MS. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$2,762 in 138 payments from 16 companies in 2025. Trend: 2023 $1,581 · 2024 $2,832 · 2025 $2,762

Food & beverage: $2,762
CompanyPaymentsAmount
ABBVIE INC.37$740
Salix Pharmaceuticals, a division of Bausch Health US, LLC21$357
Janssen Biotech, Inc.18$353
Lilly USA, LLC11$236
Regeneron Healthcare Solutions, Inc.6$190
Takeda Pharmaceuticals U.S.A., Inc.10$190
Aimmune Therapeutics, Inc.9$184
Ardelyx, Inc.6$129
Gilead Sciences, Inc.5$97
Celltrion USA Inc.4$84

Products named: TREMFYA, XIFAXAN, RINVOQ, OMVOH, CREON, DUPIXENT, ZENPEP, ENTYVIO.

Industry payments across MS — which companies pay providers there.